annual total liabilities:
$58.19B-$673.52M(-1.14%)Summary
- As of today (May 21, 2025), GSK annual total liabilities is $58.19 billion, with the most recent change of -$673.52 million (-1.14%) on December 31, 2024.
- During the last 3 years, GSK annual total liabilities has fallen by -$19.76 billion (-25.35%).
- GSK annual total liabilities is now -28.38% below its all-time high of $81.26 billion, reached on December 31, 2020.
Performance
GSK Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$60.87B+$2.68B(+4.60%)Summary
- As of today (May 21, 2025), GSK quarterly total liabilities is $60.87 billion, with the most recent change of +$2.68 billion (+4.60%) on March 31, 2025.
- Over the past year, GSK quarterly total liabilities has increased by +$3.70 billion (+6.48%).
- GSK quarterly total liabilities is now -30.90% below its all-time high of $88.09 billion, reached on March 31, 2022.
Performance
GSK quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GSK Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | +6.5% |
| 3 y3 years | -25.4% | -30.9% |
| 5 y5 years | -27.6% | -23.4% |
GSK Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.4% | at low | -30.9% | +8.7% |
| 5 y | 5-year | -28.4% | at low | -30.9% | +8.7% |
| alltime | all time | -28.4% | +8739.1% | -30.9% | +5557.3% |
GSK Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $60.87B(+4.6%) |
| Dec 2024 | $58.19B(-1.1%) | $58.19B(-2.5%) |
| Sep 2024 | - | $59.68B(+6.5%) |
| Jun 2024 | - | $56.03B(-2.0%) |
| Mar 2024 | - | $57.17B(-2.9%) |
| Dec 2023 | $58.87B(-2.8%) | $58.87B(+0.0%) |
| Sep 2023 | - | $58.86B(-1.3%) |
| Jun 2023 | - | $59.66B(+1.9%) |
| Mar 2023 | - | $58.56B(-3.3%) |
| Dec 2022 | $60.57B(-22.3%) | $60.57B(+5.1%) |
| Sep 2022 | - | $57.62B(-28.5%) |
| Jun 2022 | - | $80.54B(-8.6%) |
| Mar 2022 | - | $88.09B(+13.0%) |
| Dec 2021 | $77.96B(-4.1%) | $77.96B(+2.0%) |
| Sep 2021 | - | $76.45B(-0.3%) |
| Jun 2021 | - | $76.72B(-2.2%) |
| Mar 2021 | - | $78.44B(-3.5%) |
| Dec 2020 | $81.26B(+1.0%) | $81.26B(+4.8%) |
| Sep 2020 | - | $77.57B(-2.3%) |
| Jun 2020 | - | $79.40B(-0.2%) |
| Mar 2020 | - | $79.52B(-1.1%) |
| Dec 2019 | $80.42B(+16.5%) | $80.42B(+0.4%) |
| Sep 2019 | - | $80.13B(+4.2%) |
| Jun 2019 | - | $76.88B(-0.1%) |
| Mar 2019 | - | $76.95B(+11.5%) |
| Dec 2018 | $69.02B(-3.4%) | $69.02B(-3.5%) |
| Sep 2018 | - | $71.50B(+0.1%) |
| Jun 2018 | - | $71.40B(-3.1%) |
| Mar 2018 | - | $73.68B(+3.1%) |
| Dec 2017 | $71.48B(+7.5%) | $71.48B(-1.3%) |
| Sep 2017 | - | $72.46B(+3.5%) |
| Jun 2017 | - | $70.01B(+4.6%) |
| Mar 2017 | - | $66.93B(+0.7%) |
| Dec 2016 | $66.48B(+0.7%) | $66.48B(-6.4%) |
| Sep 2016 | - | $71.02B(-1.2%) |
| Jun 2016 | - | $71.89B(+4.3%) |
| Mar 2016 | - | $68.89B(+4.3%) |
| Dec 2015 | $66.03B(+18.8%) | $66.03B(-0.5%) |
| Sep 2015 | - | $66.36B(-3.1%) |
| Jun 2015 | - | $68.51B(-0.7%) |
| Mar 2015 | - | $68.99B(+24.1%) |
| Dec 2014 | $55.59B(-1.6%) | $55.59B(-0.9%) |
| Sep 2014 | - | $56.12B(+2.9%) |
| Jun 2014 | - | $54.53B(+1.5%) |
| Mar 2014 | - | $53.72B(-4.9%) |
| Dec 2013 | $56.52B(+0.7%) | $56.52B(+1.9%) |
| Sep 2013 | - | $55.46B(+4.5%) |
| Jun 2013 | - | $53.07B(-1.0%) |
| Mar 2013 | - | $53.60B(-4.5%) |
| Dec 2012 | $56.15B(+13.0%) | $56.15B(+3.5%) |
| Sep 2012 | - | $54.25B(+0.9%) |
| Jun 2012 | - | $53.78B(+7.9%) |
| Mar 2012 | - | $49.82B(+0.3%) |
| Dec 2011 | $49.70B(-0.9%) | $49.70B(-4.0%) |
| Sep 2011 | - | $51.74B(-1.4%) |
| Jun 2011 | - | $52.47B(-0.1%) |
| Mar 2011 | - | $52.53B(+4.8%) |
| Dec 2010 | $50.14B | $50.14B(-0.9%) |
| Sep 2010 | - | $50.59B(+1.0%) |
| Jun 2010 | - | $50.07B(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $50.29B(-3.2%) |
| Dec 2009 | $51.94B(+14.1%) | $51.94B(+2.1%) |
| Sep 2009 | - | $50.90B(+10.7%) |
| Jun 2009 | - | $45.98B(+4.3%) |
| Mar 2009 | - | $44.09B(-3.1%) |
| Dec 2008 | $45.52B(+8.5%) | $45.52B(-2.0%) |
| Sep 2008 | - | $46.43B(-6.1%) |
| Jun 2008 | - | $49.45B(+17.9%) |
| Mar 2008 | - | $41.95B(+0.0%) |
| Dec 2007 | $41.94B(+34.7%) | $41.94B(+17.2%) |
| Sep 2007 | - | $35.80B(+12.9%) |
| Jun 2007 | - | $31.70B(-0.6%) |
| Mar 2007 | - | $31.90B(+2.5%) |
| Dec 2006 | $31.14B(-7.7%) | $31.14B(+1.1%) |
| Sep 2006 | - | $30.79B(-4.5%) |
| Jun 2006 | - | $32.26B(-1.9%) |
| Mar 2006 | - | $32.87B(-2.6%) |
| Dec 2005 | $33.75B(+6.6%) | $33.75B(-0.9%) |
| Sep 2005 | - | $34.05B(+0.9%) |
| Jun 2005 | - | $33.75B(+3.4%) |
| Mar 2005 | - | $32.64B(+3.1%) |
| Dec 2004 | $31.65B(+14.3%) | $31.65B(+25.8%) |
| Sep 2004 | - | $25.16B(+2.0%) |
| Jun 2004 | - | $24.66B(-17.5%) |
| Mar 2004 | - | $29.89B(+7.9%) |
| Dec 2003 | $27.70B(+15.0%) | $27.70B(+7.2%) |
| Sep 2003 | - | $25.85B(+3.1%) |
| Jun 2003 | - | $25.06B(+8.3%) |
| Mar 2003 | - | $23.15B(-3.9%) |
| Dec 2002 | $24.08B(+22.6%) | $24.08B(+6.4%) |
| Sep 2002 | - | $22.63B(-1.4%) |
| Jun 2002 | - | $22.94B(+10.4%) |
| Mar 2002 | - | $20.78B(+5.7%) |
| Dec 2001 | $19.65B(+4.3%) | $19.65B(+2.1%) |
| Sep 2001 | - | $19.25B(+6.2%) |
| Jun 2001 | - | $18.12B(-8.2%) |
| Mar 2001 | - | $19.75B(+4.8%) |
| Dec 2000 | $18.84B(+61.2%) | $18.84B(+2.1%) |
| Sep 2000 | - | $18.45B(-2.8%) |
| Jun 2000 | - | $18.99B(-1.9%) |
| Mar 2000 | - | $19.36B(+65.6%) |
| Dec 1999 | $11.69B(+7.4%) | $11.69B(+8.8%) |
| Jun 1999 | - | $10.74B(-1.2%) |
| Dec 1998 | $10.88B(+0.3%) | $10.88B(+5.3%) |
| Jun 1998 | - | $10.33B(-4.7%) |
| Dec 1997 | $10.84B(-9.5%) | $10.84B(-9.5%) |
| Dec 1996 | $11.98B(-7.2%) | $11.98B(-0.2%) |
| Dec 1995 | $12.91B(+7.5%) | - |
| Jun 1995 | - | $12.01B(+184.7%) |
| Jun 1995 | $12.01B(+184.7%) | - |
| Jun 1994 | $4.22B(-0.2%) | $4.22B(-0.2%) |
| Jun 1993 | $4.23B(+8.9%) | $4.23B(+8.9%) |
| Jun 1992 | $3.88B(-2.8%) | $3.88B(-2.8%) |
| Jun 1991 | $3.99B(+35.8%) | $3.99B(+35.8%) |
| Jun 1990 | $2.94B(+64.1%) | $2.94B(+64.1%) |
| Jun 1989 | $1.79B(-1.5%) | $1.79B(-1.5%) |
| Jun 1988 | $1.82B(+26.3%) | $1.82B(+26.3%) |
| Jun 1987 | $1.44B(+33.8%) | $1.44B(+33.8%) |
| Jun 1986 | $1.08B(+53.8%) | $1.08B |
| Jun 1985 | $699.73M(+6.3%) | - |
| Jun 1984 | $658.37M | - |
FAQ
- What is GSK annual total liabilities?
- What is the all time high annual total liabilities for GSK?
- What is GSK annual total liabilities year-on-year change?
- What is GSK quarterly total liabilities?
- What is the all time high quarterly total liabilities for GSK?
- What is GSK quarterly total liabilities year-on-year change?
What is GSK annual total liabilities?
The current annual total liabilities of GSK is $58.19B
What is the all time high annual total liabilities for GSK?
GSK all-time high annual total liabilities is $81.26B
What is GSK annual total liabilities year-on-year change?
Over the past year, GSK annual total liabilities has changed by -$673.52M (-1.14%)
What is GSK quarterly total liabilities?
The current quarterly total liabilities of GSK is $60.87B
What is the all time high quarterly total liabilities for GSK?
GSK all-time high quarterly total liabilities is $88.09B
What is GSK quarterly total liabilities year-on-year change?
Over the past year, GSK quarterly total liabilities has changed by +$3.70B (+6.48%)